Study Title: A Single Arm, Phase I/II Trial of Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men with Localized, High Risk Prostate Cancer Big Ten Cancer Research Consortium BTCRC-GU19-404

• Closed to Accrual at:
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
• Learn more:
  • clinicaltrials.gov: NCT04737109

Study Contact: studies@hoosiercancer.org; (317) 921-2050.